216 related articles for article (PubMed ID: 33129921)
1. Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer.
Farshbaf M; Khosroushahi AY; Mojarad-Jabali S; Zarebkohan A; Valizadeh H; Walker PR
J Control Release; 2020 Dec; 328():932-941. PubMed ID: 33129921
[TBL] [Abstract][Full Text] [Related]
2. Linking cell-surface GRP78 to cancer: From basic research to clinical value of GRP78 antibodies.
Hernandez I; Cohen M
Cancer Lett; 2022 Jan; 524():1-14. PubMed ID: 34637844
[TBL] [Abstract][Full Text] [Related]
3. Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma.
Ninkovic S; Harrison SJ; Quach H
Expert Rev Hematol; 2020 Nov; 13(11):1201-1210. PubMed ID: 32990063
[TBL] [Abstract][Full Text] [Related]
4. Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells.
Wang S; Wei W; Yuan Y; Sun B; Yang D; Liu N; Zhao X
J Transl Med; 2023 Jul; 21(1):493. PubMed ID: 37481592
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review.
Akinyemi AO; Simpson KE; Oyelere SF; Nur M; Ngule CM; Owoyemi BCD; Ayarick VA; Oyelami FF; Obaleye O; Esoe DP; Liu X; Li Z
Mol Med; 2023 Aug; 29(1):112. PubMed ID: 37605113
[TBL] [Abstract][Full Text] [Related]
6. Cell-Surface GRP78-Targeted Chimeric Antigen Receptor T Cells Eliminate Lung Cancer Tumor Xenografts.
Wang S; Wei W; Yuan Y; Guo J; Liang D; Zhao X
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203736
[TBL] [Abstract][Full Text] [Related]
7. Cell surface expression of 78-kDa glucose-regulated protein (GRP78) mediates diabetic nephropathy.
Van Krieken R; Mehta N; Wang T; Zheng M; Li R; Gao B; Ayaub E; Ask K; Paton JC; Paton AW; Austin RC; Krepinsky JC
J Biol Chem; 2019 May; 294(19):7755-7768. PubMed ID: 30914477
[TBL] [Abstract][Full Text] [Related]
8. Cell Surface GRP78 as a Death Receptor and an Anticancer Drug Target.
Ge R; Kao C
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31766302
[TBL] [Abstract][Full Text] [Related]
9. Glucose-regulated protein (GRP78) is an important cell surface receptor for viral invasion, cancers, and neurological disorders.
Gonzalez-Gronow M; Gopal U; Austin RC; Pizzo SV
IUBMB Life; 2021 Jun; 73(6):843-854. PubMed ID: 33960608
[TBL] [Abstract][Full Text] [Related]
10. The COOH-Terminal Proline-Rich Region of GRP78 Is a Key Regulator of Its Cell Surface Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells.
Tseng CC; Zhang P; Lee AS
Neoplasia; 2019 Aug; 21(8):837-848. PubMed ID: 31306849
[TBL] [Abstract][Full Text] [Related]
11. A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78.
Shin J; Kim B; Lager TW; Mejia F; Guldner I; Conner C; Zhang S; Panopoulos AD; Bilgicer B
Nanoscale; 2023 Aug; 15(32):13322-13334. PubMed ID: 37526009
[TBL] [Abstract][Full Text] [Related]
12. GRP78 in lung cancer.
Xia S; Duan W; Liu W; Zhang X; Wang Q
J Transl Med; 2021 Mar; 19(1):118. PubMed ID: 33743739
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.
Miao YR; Eckhardt BL; Cao Y; Pasqualini R; Argani P; Arap W; Ramsay RG; Anderson RL
Clin Cancer Res; 2013 Apr; 19(8):2107-16. PubMed ID: 23470966
[TBL] [Abstract][Full Text] [Related]
14. Characterization and mechanism of stress-induced translocation of 78-kilodalton glucose-regulated protein (GRP78) to the cell surface.
Tsai YL; Zhang Y; Tseng CC; Stanciauskas R; Pinaud F; Lee AS
J Biol Chem; 2015 Mar; 290(13):8049-64. PubMed ID: 25673690
[TBL] [Abstract][Full Text] [Related]
15. Scratching the Surface-An Overview of the Roles of Cell Surface GRP78 in Cancer.
Chen J; Lynn EG; Yousof TR; Sharma H; MacDonald ME; Byun JH; Shayegan B; Austin RC
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625836
[TBL] [Abstract][Full Text] [Related]
16. Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions.
Crane ED; Al-Hashimi AA; Chen J; Lynn EG; Won KD; Lhoták Š; Naeim M; Platko K; Lebeau P; Byun JH; Shayegan B; Krepinsky JC; Rayner KJ; Marchiò S; Pasqualini R; Arap W; Austin RC
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568038
[TBL] [Abstract][Full Text] [Related]
17. Physiological Roles of the Autoantibodies to the 78-Kilodalton Glucose-Regulated Protein (GRP78) in Cancer and Autoimmune Diseases.
Gonzalez-Gronow M; Pizzo SV
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740249
[TBL] [Abstract][Full Text] [Related]
18. Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression.
Kia A; Przystal JM; Nianiaris N; Mazarakis ND; Mintz PJ; Hajitou A
Mol Cancer Ther; 2012 Dec; 11(12):2566-77. PubMed ID: 23053496
[TBL] [Abstract][Full Text] [Related]
19. Is GRP78 (Glucose-regulated protein 78) a prognostic biomarker in differents types of cancer? A systematic review and meta-analysis.
Dos Santos NS; Gonçalves DR; Balbinot B; Visioli F
Pathol Res Pract; 2023 Feb; 242():154301. PubMed ID: 36610326
[TBL] [Abstract][Full Text] [Related]
20. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
Fu Y; Li J; Lee AS
Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
